Key result
Adipose tissue-specific Adipsin overexpression significantly improved cardiac function in diabetic mice, increasing left ventricular ejection fraction to 59.32% compared to 49.65% in controls.
Why the study?
The specific mechanism leading to diabetic coronary microvascular hyperpermeability and disruption of adherens junctions between cardiac microvascular endothelial cells remains elusive.
Does Adipsin overexpression alleviate cardiac microvascular injury in models of diabetic cardiomyopathy?
Does Adipsin overexpression alleviate cardiac microvascular injury in models of diabetic cardiomyopathy?
Absolute Event Rate: 59.32% vs 49.65%
Adipsin protects against diabetic coronary microvascular dysfunction by maintaining endothelial adherens junctions via a Csk-dependent signaling mechanism, highlighting its potential as a therapeutic target.
May warrant preclinical validation of adipsin in diabetes; leaves open clinical translation and hard-outcome trials.
BACKGROUND: Microvascular complications are associated with an overtly increased risk of adverse outcomes in patients with diabetes including coronary microvascular injury which manifested as disruption of adherens junctions between cardiac microvascular endothelial cells (CMECs). However, particular mechanism leading to diabetic coronary microvascular hyperpermeability remains elusive. METHODS: ). In addition, cultured CMECs were subjected to high glucose/palmitic acid (HG + PA) treatment to simulate diabetes for a mechanistic approach. RESULTS: The results showed that Adipsin overexpression significantly reduced cardiac microvascular permeability, preserved coronary microvascular integrity, and increased coronary microvascular density. Adipsin overexpression also attenuated cardiac dysfunction in diabetic mice. E/A ratio, an indicator of cardiac diastolic function, was improved by Adipsin. Adipsin overexpression retarded left ventricular adverse remodeling, enhanced LVEF, and improved cardiac systolic function. Adipsin-enriched exosomes were taken up by CMECs, inhibited CMECs apoptosis, and increased CMECs proliferation under HG + PA treatment. Adipsin-enriched exosomes also accelerated wound healing, rescued cell migration defects, and promoted tube formation in response to HG + PA challenge. Furthermore, Adipsin-enriched exosomes maintained adherens junctions at endothelial cell borders and reversed endothelial hyperpermeability disrupted by HG + PA insult. Mechanistically, Adipsin blocked HG + PA-induced Src phosphorylation (Tyr416), VE-cadherin phosphorylation (Tyr685 and Tyr731), and VE-cadherin internalization, thus maintaining CMECs adherens junctions integrity. LC-MS/MS analysis and co-immunoprecipitation analysis (Co-IP) unveiled Csk as a direct downstream regulator of Adipsin. Csk knockdown increased Src phosphorylation (Tyr416) and VE-cadherin phosphorylation (Tyr685 and Tyr731), while abolishing Adipsin-induced inhibition of VE-cadherin internalization. Furthermore, Csk knockdown counteracted Adipsin-induced protective effects on endothelial hyperpermeability in vitro and endothelial barrier integrity of coronary microvessels in vivo. CONCLUSIONS: Together, these findings favor the vital role of Adipsin in the regulation of CMECs adherens junctions integrity, revealing its promises as a treatment target against diabetic coronary microvascular dysfunction. Graphical abstract depicting the mechanisms of action behind Adipsin-induced regulation of diabetic coronary microvascular dysfunction.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) studied Diabetic cardiomyopathy. Adipsin overexpression vs. Control mice with diabetes was evaluated on Left ventricular ejection fraction (LVEF). Adipose tissue-specific Adipsin overexpression significantly improved cardiac function in diabetic mice, increasing left ventricular ejection fraction to 59.32% compared to 49.65% in controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: